Are HIS vendors a threat to PACS firms?

Article

Are HIS vendors a threat to PACS firms?The PACS marketplace has traditionally been a radiology-centric business. Hospital information systems vendors have for the most part watched the PACS game from the sidelines, perhaps due to wariness about

Are HIS vendors a threat to PACS firms?

The PACS marketplace has traditionally been a radiology-centric business. Hospital information systems vendors have for the most part watched the PACS game from the sidelines, perhaps due to wariness about the large size of image data files, thorny communication service requirements, and their unfamiliarity with radiology departments. The technically demanding aspects of PACS have been best left to vendors accustomed to dealing with the needs of radiology, such as x-ray film or scanner modality vendors.

But HIS vendors are eyeing PACS as interest grows in the electronic medical record and integrated information and image management systems, and the need for these systems will only increase with the mushrooming of managed care and hospital networks. When HIS vendors begin offering PACS modules with their products, there is the definite possibility that hospitals may find this one-stop-shopping approach to information technology more attractive than being forced to buy separate IT components.

What role will PACS vendors play in this new environment? They will continue to thrive, because HIS vendors will still need the hard-earned years of expertise that PACS companies have acquired. Some PACS firms will likely partner with HIS vendors, while others will focus on radiology departments, which will remain a profitable business segment for the foreseeable future. Whatever the role, the demanding requirements of PACS ensure that vendors who have cut their teeth in this enigmatic market will not see their growing pains go for naught.

-Erik L. Ridley, Editor

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.